| 注册
首页|期刊导航|协和医学杂志|超长效镇痛药物的研发与转化

超长效镇痛药物的研发与转化

贺渝淼 李默晗 马超 黄宇光

协和医学杂志2024,Vol.15Issue(2):251-257,7.
协和医学杂志2024,Vol.15Issue(2):251-257,7.DOI:10.12290/xhyxzz.2023-0574

超长效镇痛药物的研发与转化

Development and Translation of Super Long-acting Analgesics

贺渝淼 1李默晗 1马超 2黄宇光1

作者信息

  • 1. 中国医学科学院北京协和医院麻醉科,北京 100730||中国医学科学院北京协和医院麻醉-疼痛联合实验室,北京 100730
  • 2. 中国医学科学院北京协和医院麻醉-疼痛联合实验室,北京 100730||中国医学科学院基础医学研究所北京协和医学院基础学院人体解剖与组织胚胎学系,北京 100005
  • 折叠

摘要

Abstract

Pain management,listed as the fifth vital sign,has gained increasing attention from clini-cians.Conventional analgesics have limited duration,leading to intense monitor and frequent dosing during the early phase in order to prevent the progression of chronic pain.Thus,prolonging the duration of analgesics has become one focus of the pain research.Several strategies,such as adding adjuvants,producing derivatives,and applying extended-release carriers,make it possible for super long-acting analgesics to come into reality.This review briefly introduces the strategies and development of the super long-acting analgesics,including the suc-cessful translation and commercialization of the present products of super long-acting analgesics.It also summa-rizes the application and translation of extended-release drug carriers,providing invaluable reference for the fu-ture research on the field of super long-acting analgesics.

关键词

超长效镇痛药/缓释药物载体/转化成果

Key words

super long-acting analgesics/extended-release drug carriers/translational products

分类

医药卫生

引用本文复制引用

贺渝淼,李默晗,马超,黄宇光..超长效镇痛药物的研发与转化[J].协和医学杂志,2024,15(2):251-257,7.

基金项目

中央高水平医院临床科研专项(2022-PUMCH-C-067) National High Level Hospital Clinical Research Funding(2022-PUMCH-C-067) (2022-PUMCH-C-067)

协和医学杂志

OA北大核心CSTPCD

1674-9081

访问量0
|
下载量0
段落导航相关论文